Are data from different gene expression microarray platforms comparable?

Many commercial and custom-made microarray formats are routinely used for large-scale gene expression surveys. Here, we sought to determine the level of concordance between microarray platforms by analyzing breast cancer cell lines with in situ synthesized oligonucleotide arrays (Affymetrix HG-U95v2), commercial cDNA microarrays (Agilent Human 1 cDNA), and custom-made cDNA microarrays from a sequence-validated 13K cDNA library. Gene expression data from the commercial platforms showed good correlations across the experiments (r = 0.78-0.86), whereas the correlations between the custom-made and either of the two commercial platforms were lower (r = 0.62-0.76). Discrepant findings were due to clone errors on the custom-made microarrays, old annotations, or unknown causes. Even within platform, there can be several ways to analyze data that may influence the correlation between platforms. Our results indicate that combining data from different microarray platforms is not straightforward. Variability of the data represents a challenge for developing future diagnostic applications of microarrays.

[1]  S. P. Fodor,et al.  Light-directed, spatially addressable parallel chemical synthesis. , 1991, Science.

[2]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Erez Y. Levanon,et al.  Widespread occurrence of antisense transcription in the human genome , 2003, Nature Biotechnology.

[4]  C. Li,et al.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Lockhart,et al.  Expression monitoring by hybridization to high-density oligonucleotide arrays , 1996, Nature Biotechnology.

[6]  Christopher J. Lee,et al.  A genomic view of alternative splicing , 2002, Nature Genetics.

[7]  Ravi Kothapalli,et al.  Microarray results: how accurate are they? , 2002, BMC Bioinformatics.

[8]  Terence P. Speed,et al.  Normalization for cDNA microarry data , 2001, SPIE BiOS.

[9]  Yudong D. He,et al.  Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer , 2001, Nature Biotechnology.

[10]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[11]  T. Barrette,et al.  Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. , 2002, Cancer research.

[12]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[13]  Jonathan Knight,et al.  When the chips are down , 2001, Nature.

[14]  Jaakko Astola,et al.  A novel strategy for microarray quality control using Bayesian networks , 2003, Bioinform..

[15]  D. Lockhart,et al.  Functional Genomics , 1999, Springer Netherlands.

[16]  Jin Hyun Park,et al.  Normalization for cDNA Microarray Data on the oral cancer , 2002 .

[17]  Y. Chen,et al.  Ratio-based decisions and the quantitative analysis of cDNA microarray images. , 1997, Journal of biomedical optics.

[18]  Kristina Hanspers,et al.  Spotted long oligonucleotide arrays for human gene expression analysis. , 2003, Genome research.

[19]  T R Zacharewski,et al.  Assessment of clone identity and sequence fidelity for 1189 IMAGE cDNA clones. , 2001, Nucleic acids research.

[20]  W. Cleveland.  Robust Locally Weighted Regression and Smoothing Scatterplots , 1979 .

[21]  Michael N Liebman,et al.  Characterization of adjacent breast tumors using oligonucleotide microarrays , 2001, Breast Cancer Research.

[22]  Lucila Ohno-Machado,et al.  Analysis of matched mRNA measurements from two different microarray technologies , 2002, Bioinform..

[23]  S. Sealfon,et al.  Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. , 2002, Nucleic acids research.

[24]  A. Blanchard,et al.  High-density oligonucleotide arrays , 1996 .

[25]  K. Miura,et al.  Quantitative assessment of DNA microarrays--comparison with Northern blot analyses. , 2001, Genomics.

[26]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[27]  Jiang Li,et al.  Differential gene expression patterns revealed by oligonucleotide versus long cDNA arrays. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  Michael L. Bittner,et al.  Ratio statistics of gene expression levels and applications to microarray data analysis , 2002, Bioinform..

[29]  Jason E. Stewart,et al.  Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.